ReviewNature reviews. Molecular cell biology2026
Human aminoacyl-tRNA synthetases as integrators of translation and cell signalling networks.
Review in Nature reviews. Molecular cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The regulation, function and disease relevance of cytoplasmic tRNAs.Nature reviews. Molecular cell biology · 2026Review
- Aminoacyl-tRNA synthetases in tumor immunity: canonical translation, source-resolved immune circuits and therapeutic opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aminoacyl-tRNA synthetases (ARSs) are best known for their central role in translation, where they attach specific amino acids to their matching tRNAs to ensure accurate protein synthesis. However, in humans, these enzymes have evolved far beyond this textbook function. Emerging research reveals that ARSs have versatile roles in cells, acting as sensors, signalling hubs and regulators of cellular and systemic homeostasis. The structural adaptability of ARSs enables them to connect metabolic cues with gene expression, protein networks and stress responses. Disruptions in ARS functions are increasingly linked to a wide range of diseases, from cancer to neurodegeneration. In this Review, we examine how ARSs operate at the intersection of translation and signalling networks: we discuss their catalytic regulation functions, structural diversification, non-canonical functions such as in transcription and translation regulation, protein degradation and signal transduction and their disease relevance. By bringing these insights together, we offer a unified view of ARSs as multifaceted proteins and open new avenues for discoveries in molecular biology, pathophysiology and drug design.
Identifiers
42399431What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.